Cardinal Health, Inc. (CAH)
NYSE: CAH · Real-Time Price · USD
148.62
+0.40 (0.27%)
At close: May 12, 2025, 4:00 PM
150.00
+1.38 (0.93%)
After-hours: May 12, 2025, 7:27 PM EDT
Cardinal Health Market Cap
Cardinal Health has a market cap or net worth of $35.47 billion as of May 12, 2025. Its market cap has increased by 40.85% in one year.
Market Cap
35.47B
Enterprise Value
39.83B
1-Year Change
40.85%
Ranking
Category
Stock Price
$148.62
Market Cap Chart
Since December 1, 1998, Cardinal Health's market cap has increased from $13.56B to $35.47B, an increase of 161.57%. That is a compound annual growth rate of 3.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 35.38B | 23.60% |
| Dec 31, 2024 | 28.62B | 15.21% |
| Dec 29, 2023 | 24.84B | 23.29% |
| Dec 30, 2022 | 20.15B | 38.88% |
| Dec 31, 2021 | 14.51B | -7.68% |
| Dec 31, 2020 | 15.72B | 6.23% |
| Dec 31, 2019 | 14.79B | 11.33% |
| Dec 31, 2018 | 13.29B | -31.06% |
| Dec 29, 2017 | 19.28B | -16.32% |
| Dec 30, 2016 | 23.04B | -21.56% |
| Dec 31, 2015 | 29.37B | 9.92% |
| Dec 31, 2014 | 26.72B | 17.11% |
| Dec 31, 2013 | 22.81B | 63.05% |
| Dec 31, 2012 | 13.99B | -0.28% |
| Dec 30, 2011 | 14.03B | 4.95% |
| Dec 31, 2010 | 13.37B | 14.33% |
| Dec 31, 2009 | 11.69B | -5.67% |
| Dec 31, 2008 | 12.40B | -40.63% |
| Dec 31, 2007 | 20.88B | -19.98% |
| Dec 29, 2006 | 26.09B | -11.36% |
| Dec 30, 2005 | 29.44B | 17.18% |
| Dec 31, 2004 | 25.13B | -5.11% |
| Dec 31, 2003 | 26.48B | 1.10% |
| Dec 31, 2002 | 26.19B | -10.16% |
| Dec 31, 2001 | 29.15B | 4.84% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |